# Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing

> **NCT07533422** · NA · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 531 (estimated)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS
- Rescue Therapy for Helicobacter Pylori

## Interventions

- **DRUG:** Personalized treatment based on the results of fecal antimicrobial resistance gene testing
- **DRUG:** Conventional Quadruple Therapy

## Key facts

- **NCT ID:** NCT07533422
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-12
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-02-01
- **Target enrollment:** 531 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533422, "Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07533422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*